Free Trial

SmileDirectClub (SDCCQ) Competitors

$0.0002 0.00 (0.00%)
(As of 12:49 PM ET)

SDCCQ vs. BIOL, IONM, GMVDF, VRAYQ, AHPI, NMRD, MOTS, BRSH, DRTSW, and ANZUW

Should you be buying SmileDirectClub stock or one of its competitors? The main competitors of SmileDirectClub include BIOLASE (BIOL), Assure (IONM), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.

SmileDirectClub vs.

BIOLASE (NASDAQ:BIOL) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.

In the previous week, BIOLASE had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 1 mentions for BIOLASE and 0 mentions for SmileDirectClub. BIOLASE's average media sentiment score of 0.12 beat SmileDirectClub's score of 0.00 indicating that BIOLASE is being referred to more favorably in the media.

Company Overall Sentiment
BIOLASE Neutral
SmileDirectClub Neutral

BIOLASE has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500.

BIOLASE has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIOLASE$48.83M0.00-$20.63M-$14.940.00
SmileDirectClub$470.74M0.00-$86.40MN/AN/A

SmileDirectClub has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. SmileDirectClub's return on equity of 0.00% beat BIOLASE's return on equity.

Company Net Margins Return on Equity Return on Assets
BIOLASE-41.65% -1,782.73% -55.31%
SmileDirectClub N/A N/A N/A

8.8% of BIOLASE shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 0.3% of BIOLASE shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

BIOLASE received 292 more outperform votes than SmileDirectClub when rated by MarketBeat users.

CompanyUnderperformOutperform
BIOLASEOutperform Votes
292
53.09%
Underperform Votes
258
46.91%
SmileDirectClubN/AN/A

BIOLASE presently has a consensus target price of $1.20, indicating a potential upside of 23,900.00%. Given BIOLASE's stronger consensus rating and higher probable upside, equities analysts clearly believe BIOLASE is more favorable than SmileDirectClub.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIOLASE
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
SmileDirectClub
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

BIOLASE beats SmileDirectClub on 9 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

MetricSmileDirectClubDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$81,000.00$3.47B$5.03B$8.81B
Dividend YieldN/A1.85%5.16%4.06%
P/E RatioN/A37.26135.4117.82
Price / Sales0.001.951,160.9774.56
Price / CashN/A5.3533.5332.53
Price / Book0.002.084.674.68
Net Income-$86.40M-$33.08M$119.07M$226.08M
7 Day PerformanceN/A3.95%-1.83%-1.04%
1 Month PerformanceN/A-7.46%-3.60%1.04%
1 Year PerformanceN/A134.51%31.66%26.28%

SmileDirectClub Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/A$0.00
flat
N/A-99.4%$81,000.00$470.74M0.002,700Gap Down
BIOL
BIOLASE
1.1208 of 5 stars
$0.01
flat
$1.20
+23,900.0%
-99.6%$167,000.00$48.83M0.00160Analyst Forecast
News Coverage
IONM
Assure
N/A$0.04
flat
N/A-99.2%$141,000.00$250,000.000.00130
GMVDF
G Medical Innovations
N/AN/AN/AN/A$30,000.00$4.42M0.0072
VRAYQ
ViewRay
N/AN/AN/AN/A$20,000.00$102.21M0.00300
AHPI
Allied Healthcare Products
N/AN/AN/AN/A$16,000.00$27.05M0.00150
NMRD
Nemaura Medical
N/AN/AN/AN/A$10,000.00$80,000.000.0040
MOTS
Motus GI
N/A$0.00
flat
N/A-100.0%$5,000.00$320,000.000.0030
BRSH
Bruush Oral Care
N/A$0.00
flat
N/A-99.7%$1,000.00$2.92M0.0011
DRTSW
Alpha Tau Medical
N/A$0.22
+29.8%
N/A-15.4%$0.00N/A0.0080News Coverage
Gap Up
ANZUW
Anzu Special Acquisition Corp I
N/A$0.06
flat
N/AN/A$0.00N/A0.002

Related Companies and Tools


This page (NASDAQ:SDCCQ) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners